Kotomi Ikuma

Title: Kotomi Ikuma: Innovator in Preterm Delivery Solutions

Introduction

Kotomi Ikuma is a notable inventor based in Shizuoka, Japan. She has made significant contributions to the field of maternal health, particularly in the diagnosis and prevention of preterm delivery and miscarriage. Her innovative approach has the potential to improve outcomes for pregnant women at risk.

Latest Patents

Kotomi Ikuma holds a patent for a therapeutic agent aimed at addressing preterm delivery or abortion using plasminogen activator inhibitor-1. This patent describes a method for diagnosing the risk of preterm delivery or miscarriage in pregnant women. The method involves measuring the activity or level of plasminogen activator inhibitor-1 in plasma isolated from the pregnant woman. If the activity or level is found to be lower than that of a normal pregnant woman, it indicates a risk for preterm delivery or miscarriage. The patent also includes the administration of plasminogen activator inhibitor-1 to those identified at risk, along with a kit for diagnosing the degree of risk and a pharmaceutical composition for prevention.

Career Highlights

Throughout her career, Kotomi Ikuma has worked with esteemed institutions such as Hamamatsu University School of Medicine and the National University Corporation Hamamatsu University School of Medicine. Her work has been pivotal in advancing research and practical applications in maternal health.

Collaborations

Kotomi has collaborated with notable colleagues, including Kazuo Umemura and Takayuki Iwaki. Their combined efforts have contributed to the development of innovative solutions in the field.

Conclusion

Kotomi Ikuma's contributions to the field of maternal health through her patent and collaborative efforts highlight her role as an influential inventor. Her work aims to enhance the well-being of pregnant women and improve health outcomes for both mothers and their children.